BioSpace News Archive

The new USP Compounded Preparation Monograph for Ondansetron Compounded Topical Gel (20 mg/ml) includes PCCA’s proprietary topical base as a key ingredient

New additions deepen PTCB connections to pharmacy stakeholders.

Poteligeo has been approved for the treatment of the two most common types of Cutaneous T-cell lymphoma (CTCL) in previously treated patients based on data showing improved progression-free survival (PFS) and overall response rate (ORR) when compared to vorinostat.

IRB Approved Clinical study measuring standard spirometry parameters demonstrates that compressor-style vests do not increase cephalad airflow bias in the lungs [08-August-2018] AUSTIN, Texas, Aug. 8, 2018 /PRNewswire/ -- International Biophysics Corporation, a 26-year-old global medical device manufacturer based in Austin, Texas, announced today the publica

Neovasc, Inc. announced that Fred Colen, President and Chief Executive Officer of Neovasc, is now scheduled to present at the 38th Annual Canaccord Genuity Growth Conference on Thursday, August 9th at 12:30 pm ET being held in Boston, Massachusetts.

Unparalleled precision provides patients with a customized joint replacement surgery for restored mobility

RSP Systems A/S, the non-invasive diagnostics company, announces that it has received the ISO 13485:2016 certificate, demonstrating commitment to placing its non-invasive glucose meter for diabetes management on the market.

Oxford Gene Technology (OGT), The Molecular Genetics Company, has announced the launch of the eagerly-anticipated update to its SureSeq™ Interpret software, included with purchases of SureSeq NGS panels.

Champions Oncology, Inc. (Nasdaq: CSBR), engaged in the development of advanced technology solutions and services to personalize the development and use of oncology drugs, today announced that its new facility in Rockville, MD has been granted Full Accreditation by the Association for Assessment and Accreditation of Laboratory Animal Care (AAALAC) International.

Global pharmaceutical company Mylan N.V.'sboard of directors today released the following statement